Provepharm life Solutions SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Provepharm life Solutions SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10692
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provepharm life Solutions SA (Provepharm) is a life sciences research and pharmaceutical company which focuses on innovative specialty care products for hospitals. The company’s product portfolio includes; methylthioninium chloride proveblue, provayblue methylene blue, proveblue methylene blue, proveblue solution. It also offers research and manufacturing services to vitalize pharmaceutical and cosmetic research programs in small molecules and peptide chemistry and commercializes preclinical and clinical projects from development stage to market. Provepharm is established in Marseille, Provence-Alpes-Cote d’Azur, France.

Provepharm life Solutions SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provepharm life Solutions SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Provepharm Partners with DFKC 10
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 11
Licensing Agreements 12
Provepharm Enters Into Licensing Agreement With NordMedica 12
Provepharm life Solutions SA – Key Competitors 13
Provepharm life Solutions SA – Key Employees 14
Provepharm life Solutions SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Key Facts 2
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provepharm life Solutions SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provepharm life Solutions SA, Deals By Therapy Area, 2012 to YTD 2018 8
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Provepharm Partners with DFKC 10
Provepharm Enters Into Distribution Agreement With Fresenius Kabi Pharma 11
Provepharm Enters Into Licensing Agreement With NordMedica 12
Provepharm life Solutions SA, Key Competitors 13
Provepharm life Solutions SA, Key Employees 14

List of Figures
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provepharm life Solutions SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Provepharm life Solutions SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • British Airways Plc:企業の戦略的SWOT分析
    British Airways Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • ConvaTec Group Plc (CTEC):医療機器:M&Aディール及び事業提携情報
    Summary ConvaTec Group Plc (ConvaTec) is a medical products and technologies company that specializes in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheter …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • Andersen Construction Co:企業の戦略的SWOT分析
    Andersen Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Oryzon Genomics SA (ORY):企業の財務・戦略的SWOT分析
    Summary Oryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup o …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務情報
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Crinetics Pharmaceuticals Inc (CRNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crinetics Pharmaceuticals Inc (Crinetics) is a developer of novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related cancers. The company’s products include neuropeptides and their receptors, orally-available somatostatin agon …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations inc …
  • PNM Resources, Inc.:発電所・企業SWOT分析
    PNM Resources, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BioLight Israeli Life Sciences Ltd (BOLT):医療機器:M&Aディール及び事業提携情報
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light), formerly Bio Light Israeli Life Sciences Investments Ltd is an ophthalmic company that discovers, develops and commercializes products and product candidates for various ophthalmic conditions. The company invests in managing and commercializing …
  • Landsvirkjun hf:企業の戦略的SWOT分析
    Landsvirkjun hf - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Electricidade de Mocambique EP:電力:M&Aディール及び事業提携情報
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. It produces electricity from hydro and thermal sources. The company has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Cabot Oil & Gas Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cabot Oil & Gas Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cabot Oil & Gas Corp (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sultan Center Food Products Co. KSC (SULTAN):企業の財務・戦略的SWOT分析
    Sultan Center Food Products Co. KSC (SULTAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆